Vanguard
http://www.vanguard.com/Vanguard, an investment management company, offers mutual funds and other financial products and services to institutional and individual investors worldwide.
View Older Stories View More Recent Stories
-
L3Harris Expands Satellite Production Site, Adds Unclassified Satellite Line for National Defense
-
Vanguard Announces Cash Distributions For The Vanguard ETFs
-
AMC Networks (AMCX) president and CEO Josh Sapan has notified company of his desire to transition to executive vice chairman
-
AMC Networks Announces Leadership Changes
-
AMC Networks Announces Leadership Changes
-
Survey Says...Electronic Arts (EA) Battlefield Not Impacting Demand for Activision's (ATVI) CoD - Jefferies
-
Cyclerion Therapeutics to Present at Annual Biomarkers for Alzheimer’s Disease Summit
-
Cyclerion Therapeutics to Present at Annual Biomarkers for Alzheimer’s Disease Summit
-
Sage Growth Partners Expands Marketing Team with Four New Hires
-
PGS Completes Another Successful GeoStreamer X Program
-
New Horizon Health Announces 2021 Interim Results: Revenue Increases 317% Year-on-year, Gross Profit Margin Climbs to 56.2%
-
Stephen Collins Leads the Nation in Record-Breaking Fundraising for The Leukemia and Lymphoma Society
-
The American Council of Learned Societies Names 48 New Emerging Voices Fellows
-
Yext, Inc. to Report Second Quarter Fiscal Year 2022 Financial Results on September 2, 2021
-
Exclusive: Activist hedge fund Starboard hires analyst from BlackRock's stewardship team
-
Rise on Every Front, Call of Duty®: Vanguard to Launch November 5
-
Roger West Makes Key Hires in High-Growth Areas of Email Marketing and Client Strategy
-
REAL SIMPLE Reveals Winners of the 2021 Smart Money Awards
-
Getaway Announces Company-Wide Closure, Giving All Full-Time & Part-Time Employees Paid Week Off
-
Adagene Inc. (ADAG) Announces Collaboration with Merck for Trial of Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)
-
Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)
-
Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)
-
Yext Announces Yext AI Search for Salesforce Service Cloud on Salesforce AppExchange, the World's Leading Enterprise Cloud Marketplace
-
Simfoni Brings On David Bush As CEO Of Spend Automation
-
Bestow Named Winner of Real Simple's 2021 Smart Money Awards
-
Tafi Joins Vibrant Vancouver Tech Hub with New Canadian Entity
-
GoodCell Expands Expert Leadership With Advisor Addition of MedTech Evangelist Dr. Jennifer Joe
-
Dentist Advisors Hires Amanda Bateman, CFP® as a Financial Advisor
-
Telix and Merck to Commence Pan-Cancer Clinical Combination Studies
-
Telix and Merck KGaA, Darmstadt, Germany, to Commence Pan-Cancer Clinical Combination Studies
-
Elbert Memorial Hospital Deploys LightStrike Germ-Zapping Robots; First Hospital in Region to Deploy Coronavirus-Killing Technology
-
Huge Eliminates Barriers to Entry for Underrepresented Identities in the Design Industry with Huge XD School
-
Celent Awarded NexJ an XCelent Award in the Advanced Technology Category, Recognizing NexJ's CRM Technology for Wealth Management
-
Skyborg Vanguard Takes Next Steps Toward Program of Record
-
Vanguard Mega Cap Growth Etf (MGK) 30-day option implied volatility near low end of range
-
Fusion Fuel Green Receives Approval for €4.3 million in POSEUR Funding for HEVO-Sul Project
-
Fusion Fuel Green Receives Approval for €4.3 million in POSEUR Funding for HEVO-Sul Project
-
Digital.com Announces Best Commercial Cleaning Services of 2021
-
Form 13F-NT Vanguard Global Advisers For: Jun 30
-
Form 13F-NT VANGUARD ADVISERS INC For: Jun 30
-
Form 13F-NT VANGUARD ASSET MANAGEMEN For: Jun 30
-
Form 13F-NT Vanguard Investments For: Jun 30
-
Form 13F-NT VANGUARD FIDUCIARY TRUST For: Jun 30
-
Form 13F-HR VANGUARD GROUP INC For: Jun 30
-
Pleio's CEO And GoodStart™ Program Named PM360 2021 Trailblazer Finalist In Two Categories
-
McDermott's Health Practice Launches in Atlanta with Partner, Counsel Additions
-
Adagene Inc. (ADAG) Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board
-
Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board
-
Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board
-
Global Agrochemicals Market Size Expected to Reach $335 Billion in 2026


